Use App
Trending
News
Earnings
All
DIA
0.09%
SPY
0.01%
QQQ
0.27%
Trending
HOOD
10.32%
SOFI
2.45%
DOGE
10.72%
SNDK
5.96%
CRML
6.75%
LTC
4.30%
BE
15.60%
BSX
0.10%
RLS
83.44%
STX
17.12%
HOOD
10.32%
SOFI
2.45%
DOGE
10.72%
SNDK
5.96%
CRML
6.75%
LTC
4.30%
BE
15.60%
BSX
0.10%
RLS
83.44%
STX
17.12%
home
Symbol
CNSP
news
CNSP
Cns Pharmaceuticals Inc
7,716
Mkt Cap
$1.86M
Volume
4,849.00
52W High
$34.80
52W Low
$1.90
PE Ratio
-0.05
CNSP Fundamentals
Price
$2.26
Prev Close
$2.29
Open
$2.31
50D MA
$2.65
Beta
1.12
Avg. Volume
46,893.32
EPS (Annual)
-$35.75
P/B
0.32
Rev/Employee
$0.00
$4.54
PE Ratio
-0.05
Loading...
Loading...
Feed
News
Sentiment
Fundamentals
Info
News
all
press releases
CNS Pharmaceuticals Stock Declines On Wider Q1 Loss: But Retail Stays Unmoved
The company intends to commence the phase 2 study of its lead program, TPI 287, to treat Glioblastoma Multiforme (GBM) by year-end.
Stocktwits
·
1y ago
Full Article
<
...
1
>
Latest CNSP News
View
Advertisement
|
Remove ads.
Top Discussions
top
active
trending
Advertisement
|
Remove ads.
Advertisement
|
Remove ads.
Watchlist
Trending
News
Explore
Community
Profile